Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4355-4362

  Vivian, Hwa ^a   Tomasini Sprenger, Cindy ^b   López Bermejo, Abel ^a   Rosenfeld, Ron G ^a   Plymate, Steven R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Educ Clin Ctr (GRECC)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; PEPTIDE HORMONE; REGULATOR PROTEIN; RETINOIC ACID; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ACROMEGALY; ARTICLE; CELL GROWTH; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0032452436     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.12.5341     Document Type: Article

References (48)

1. 1. Cohen P, Peehl DM, Rosenfeld R. 1991 Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary ultures of prostate epithelial cells. J Clin Endocrinol Metab. 73:401-407.
2. 2. Connolly JM, Rose DP. 1994 Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate. 24:167-175.
3. 3. Iwamura M, Sluss PM, Casamento JB, Cockett AT. 1993 Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate. 22:243-252.
4. 4. Angelloz-Nicoud P, Binoux M. 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology. 136:5485-5492.
5. 5. Chan J, Stampfer M, Giovannucci E, et al. 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 279:563-566.
6. 6. Colao A, Marzullo P, Ferone D, et al. 1998 Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab. 83:775-779.
7. 7. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res. 3:243-266.
8. 8. Shimasaki S, Shimonaka M, Zhang H-P, Ling N. 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 266:10646-10653.
9. 9. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
10. 10. Kelley K, Oh Y, Gargosky S, et al. 1996 Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 28:619-637.
11. 11. Clemmons D, Cascieri M, Camacho-Hubner C, McCusker R, Bayne M. 1990 Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem. 265:1216-1220.
12. 12. Ross M, Francis G, Szabo L, Wallace J, Ballard J. 1989 Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3)-IGF-I. Biochem J. 258:267-272.
13. 13. Elgin R, Busby W, Clemmons D. 1987 An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA. 84:3254-3258.
14. 14. Oh Y, Muller HL, Pham H, Rosenfeld RG. 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem. 268:26045-26048.
15. 15. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 9:361-367.
16. 16. Mohan S, Nakao Y, Honda Y, et al. 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem. 270:20424-20431.
17. 17. Bork P. 1993 The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327:125-130.
18. 18. Oh Y, Nagalla SR, Yamanaka Y, et al. 1996 Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7). J Biol Chem. 271:30322-30325.
19. 19. Kim H-S, Nagalla SR, Oh Y, et al. 1997 Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA. 94:12981-12986.
20. 20. Hwa V, Oh Y, Rosenfeld RG. Insulin-like growth factor binding protein (IGFBP) superfamily. Acta Paediatr Scand. In press.
21. 21. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y. 1997 Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 272:30729-30734.
22. 22. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. 1993 Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ. 4:715-722.
23. 23. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. 1991 Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 114:1285-1294.
24. 24 Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. 1994 Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab. 79:1410-1415.
25. 25. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton B. 1996 Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab 81:612-617.
26. 26. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. 1996 Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocardnoma of the prostate. J Clin Endocrinol Metab. 81:411-420.
27. 27. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. 1996 Insulin-like growth factor binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J Clin Endocrinol Metab. 81:3783.
28. 28. Birnbaum R, Ware J, Plymate S. 1994 Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrinol. 141:535-540.
29. 29. Hwa V, Oh Y, Rosenfeld RG. 1997 Insulin-like growth factor protein-3 and -5 are regulated by transforming growth factor-β2 and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine. 6:235-242.
30. 30. Kimura G, Kasuya J, Giannini S, et al. 1996 Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol. 3:39-46.
31. 31. Kanety H, Madjar Y, Dagan Y, et al. 1993 Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab. 77:229-233.
32. 32. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG. 1993 Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:1031-1035.
33. 33. Angelloz-Nicoud P, Harel L, Binoux M. 1996 Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regul. 6:130-136.
34. 34. Cohen P, Peehl D, Graves H, Rosenfeld R. 1994 Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease. J Endocrinol. 142:407-415.
35. 35. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem. 268:14964-14971.
36. 36. Lalou C, Lassarre C, Binoux M. 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology. 137:3206-3212.
37. 37. Rajah R, Valentinis B, Cohen P. 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed ceel death through a p53-and IGF-independent mechanism. J Biol Chem. 272:12181-12188.
38. 38. Swisshelm K, Ryan K, Tsuchiya K, Sager R. 1995 Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA. 92:4472-4476.
39. 39. Akaogi K, Okabe Y, Funahashi K, et al. 1994 Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem Biophys Res Commun. 198:1046-1053.
40. 40. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H. 1994 Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J. 303:591-598.
41. 41. Akaogi K, Sato J, Okabe Y, Sakamoto Y, Yasumitsu H, Miyazaki K. 1996 Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ. 7:1671-1677.
42. 42. Akaogi K, Okabe Y, Sato J, et al. 1996 Specific accumulation of tumor-derived adhesion factor in tumor vascular endothelial cells. Proc Natl Acad Sci USA. 93:8384-8389.
43. 43. Bae V, Jackson-Cook C, Brothman A, Maygarden S, Ware J. 1994 Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor expression. Int J Cancer. 58:721-729.
44. 44. Wilson E, Oh Y, Rosenfeld RG. 1997 Generation and characterization of an IGFBP-7 antibody: identification of 31kD IGFBP-7 in human biological fluids and Hs578T breast cancer conditioned media. J Clin Endocrinol Metab. 82:1301-1303.
45. 45. Jackson-Cook C, Bae V, Edelman W, Brothman A, Ware J. 1996 Cytogenetic characterization of the human prostate cancer cell Une P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet Cytogenet. 87:14-23.
46. 46. Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL. 1996 The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40T antigen. J Clin Endocrinol Metab. 81:3709-3716.
47. 47. Oh Y, Muller HL, Ng L, Rosenfeld RG. 1995 Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem. 270:13589-13592.
48. 48. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. 1996 Insulin-like growth factor binding protein-3 (IGFBP-3) mediates retinoic acid (RA) and transforming growth factor-β2 (TGFβ2) induced growth inhibition in human breast cancer cells. Cancer Res. 56:1545-1550.